Drug-labels.com

Ventolin I.M. Injection 0.5mg Salbutamol in 1 mL (500mcg/mL): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
0.5 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Ventolin I.M. Injection 0.5mg Salbutamol in 1 mL (500mcg/mL)

ABOUT THIS MEDICATION

What the medication is used for:

Your doctor has prescribed a medicine called VENTOLIN® I.M. injection for you. It is used to help breathing problems in:

$ Asthma

$ Other chest illnesses.

VENTOLIN® I.M. injection must only be administered by a health professional. It may be injected into muscle tissue or into a vein. Do not try to use VENTOLIN® I.M. injection on your own.

What it does:

Salbutamol is one of a group of medicines called bronchodilators. Salbutamol relaxes the muscles in the walls of the small air passages in the lungs. This helps to open up the airways and so helps to relieve chest tightness, wheezing and cough so that you can breathe more easily.

When it should not be used:

Do not use VENTOLIN® I.M. injection if:

$ you are allergic to it or any of the components of its

formulation (see what the important nonmedicinical ingredients are)

$ your heart beats faster than normal

$ you are at risk of miscarriage

What the medicinal ingredient is:

VENTOLIN® I.M. injection contains the active ingredient, salbutamol sulphate.

What the important nonmedicinal ingredients are:

VENTOLIN® I.M. injection contains sodium chloride, sulphuric acid and/or sodium hydroxide and water.

What dosage forms it comes in:

VENTOLIN® I.M. injection comes in ampules of 1 mL each containing 0.5 mg of Salbutamol as Salbutamol Sulphate.

WARNINGS AND PRECAUTIONS

Before you use VENTOLIN® I.M. injection, talk to your doctor or pharmacist if:

  • you have ever had to stop taking other medications for this illness because you were allergic to them or they caused problems.
  • you are having treatment for a thyroid condition.
  • you are having treatment for high blood pressure or a heart problem.
  • if you have diabetes.
  • if you have a past history of seizures.
  • if you are pregnant or breastfeeding.

Rare cases of lactic acidosis (too much lactic acid in the blood) have been reported in patients receiving high doses of VENTOLIN® I.M. injection. If you suffer symptoms (see Serious Side Effects Table), contact your doctor immediately.

If you notice that your shortness of breath or wheeze is becoming worse, tell your doctor as soon as possible. If the relief of wheezing or chest tightness is not as good as usual, tell your doctor as soon as possible. It may be that your chest condition is worsening and you may need to add another type of medicine to your treatment.

Your doctor may decide not to prescribe this medicine during the first three months of pregnancy, or if you are breast feeding a baby. However, there may be circumstances when your doctor advises you differently.

Labour and delivery

It has been reported that high doses of VENTOLIN®

(salbutamol) injection can slow down labour (uterine contractions), but VENTOLIN® is not approved for the treatment of premature labour in Canada. Due to the risk of heart and circulation side effects (see Side Effects And What To Do About Them) and so as to avoid interference with uterine contractions, VENTOLIN® injection should be used with caution if given to pregnant patients with breathing problems during labour.

INTERACTIONS WITH THIS MEDICATION

Make sure that your doctor knows what other medicines you are taking (such as those for depression, allergies, other airway-opening medications (e.g. other asthma medications), blood pressure and heart medications, and water pills (diuretics), etc.), including those you can buy without a prescription as well as herbal and alternative medicines.

PROPER USE OF THIS MEDICATION

VENTOLIN® I.M. injection should not be self administered by an individual. It should be administered under the supervision of a health professional.

Usual dose:

500 micrograms (8 micrograms/kg body weight) every 4 hours as required.

Maximum daily dose: 2000 micrograms

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Very occasionally, some people feel a little shaky or have a headache or notice that their heart is beating a little faster and/or more forcefully than usual after using VENTOLIN®. Muscle cramps can occur, although these are quite rare. These effects usually wear off within a few hours, but you should tell your doctor as soon as possible. If you have chest pain, if your heart beat feels irregular, or feel unwell in any other way or have any symptoms that you do not understand, you should contact your doctor immediately.

Tell your doctor at once if you develop breathlessness, wheezing, chest pain or cough as these may be signs of increased fluid in the lungs (pulmonary edema). Chest pain may also be a sign of reduced blood supply to the heart muscle (myocardial ischaemia).

This is not a complete list of side effects. If you have any unexpected effects after receiving VENTOLIN® I.M. injection, contact your doctor or pharmacist.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM

* If you think you have these side effects, it is important that you seek medical advice from your doctor immediately.

HOW TO STORE IT

Keep VENTOLIN® I.M. injection away from light and store between 15°C and 30°C.

Symptom/effectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist*
Only if severeIn all cases
Very Rare

Increased

wheezing or

tightness in the chest or difficulty in breathing (sign of

bronchospasm).

9

Allergic reactions (Hypersensitivity) Swelling of the eyelids, face, lips, tongue or throat, accompanied by difficulty in

breathing,

speaking or

swallowing (signs of angioedema). Skin rash, skin eruption or other effect on the skin or eyes, itching or fever. Fainting when the blood pressure is too low (sign of

hypotension).

9

Deep and rapid breathing,

vomiting,

abdominal pain, weight loss,

fatigue, malaise (sign of lactic acidosis-too

much lactic acid in the blood)

9

REPORTING SUSPECTED SIDE EFFECTS

To monitor drug safety, Health Canada collects information on serious and unexpected effects of drugs . If you suspect you have had a serious or unexpected reaction to this drug you may notify Health Canada by:

toll-free telephone: 866-234-2345 toll-free fax 866-678-6789

By email: cadrmp@hc-sc.gc.ca

By regular mail:

National AR Centre

Marketed Health Products Safety and Effectiveness Information Division

Marketed Health Products Directorate

Tunney’s Pasture, AL 0701C

Ottawa ON K1A 0K9

NOTE: Before contacting Health Canada, you should contact your physician or pharmacist.

MORE INFORMATION

You may need to read this leaflet again. PLEASE DO NOT THROW IT AWAY until you have finished your medicine.

This document plus the full product monograph, prepared for health professionals can be obtained by contacting the sponsor,

GlaxoSmithKline Inc.

7333 Mississauga Road

Mississauga, Ontario

L5N 6L4

1-800-387-7374

Last revised: November 16, 2006

© 2006 GlaxoSmithKline Inc. All Rights Reserved

®VENTOLIN is a registered trademark, used under license by GlaxoSmithKline Inc.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02213443

Revision date stated in the text: November 16, 2006

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ventolin I.M. Injection 0.5mg Salbutamol in 1 mL (500mcg/mL)

Rx or OTC
Prescription (Rx)?
DIN 02213443
Schedule(s) PRESCRIPTION
Active ingredient(s) Salbutamol (salbutamol sulfate) 0.5 MG
Dosage form(s) Solution
Route(s) of administration Intramuscular
Drug class (WHO ATC)
  1. R Respiratory system drugs
    1. R03 Drugs for obstructive airway diseases
      1. R03C Adrenergics for systemic use
        1. R03CC Selective beta-2-adrenoreceptor agonists, systemic
          1. R03CC02 Salbutamol
Company GLAXOSMITHKLINE INC
Current status Cancelled Post Market
Current status date April 19, 2007

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.